|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US6645988B2
(en)
*
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
|
US6096340A
(en)
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
|
US6174548B1
(en)
*
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
|
ES2373864T3
(es)
*
|
1998-04-20 |
2012-02-09 |
Eisai R&D Management Co., Ltd. |
Composición estabilizada que contiene un compuesto de tipo bencimidazol.
|
|
SE9803772D0
(sv)
*
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Pharmaceutical formulation
|
|
SE9902386D0
(sv)
*
|
1999-06-22 |
1999-06-22 |
Astra Ab |
New formulation
|
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
|
ES2168043B1
(es)
|
1999-09-13 |
2003-04-01 |
Esteve Labor Dr |
Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
|
|
AU782538B2
(en)
|
1999-10-20 |
2005-08-04 |
Eisai Co. Ltd. |
Method for stabilizing benzimidazole compounds
|
|
US20040092511A1
(en)
*
|
1999-12-10 |
2004-05-13 |
Billstein Stephan Anthony |
Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders
|
|
US20020192299A1
(en)
*
|
2000-12-28 |
2002-12-19 |
Rajneesh Taneja |
Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
|
|
JP2002234842A
(ja)
*
|
2001-02-09 |
2002-08-23 |
Kyowa Yakuhin Kogyo Kk |
内服腸溶性製剤
|
|
WO2003063840A2
(en)
*
|
2002-01-25 |
2003-08-07 |
Santarus, Inc. |
Transmucosal delivery of proton pump inhibitors
|
|
US20040082618A1
(en)
*
|
2002-07-03 |
2004-04-29 |
Rajneesh Taneja |
Liquid dosage forms of acid labile drugs
|
|
FR2843121B3
(fr)
|
2002-08-02 |
2004-09-10 |
Rhodia Chimie Sa |
Agent ignifugeant, procede de preparation et l'utilisation de cet agent
|
|
US20070243251A1
(en)
*
|
2002-12-20 |
2007-10-18 |
Rajneesh Taneja |
Dosage Forms Containing A PPI, NSAID, and Buffer
|
|
US20040121004A1
(en)
*
|
2002-12-20 |
2004-06-24 |
Rajneesh Taneja |
Dosage forms containing a PPI, NSAID, and buffer
|
|
US20040146558A1
(en)
*
|
2003-01-28 |
2004-07-29 |
Kyowa Pharmaceutical Co., Ltd. |
Oral enteric-coated preparation
|
|
CN1761465B
(zh)
*
|
2003-01-29 |
2010-10-13 |
武田药品工业株式会社 |
制备被覆制剂的方法
|
|
WO2004067001A1
(ja)
*
|
2003-01-29 |
2004-08-12 |
Takeda Pharmaceutical Company Limited |
被覆製剤の製造法
|
|
JP4567340B2
(ja)
*
|
2003-01-29 |
2010-10-20 |
武田薬品工業株式会社 |
被覆製剤の製造方法
|
|
RU2359671C2
(ru)
*
|
2003-01-29 |
2009-06-27 |
Такеда Фармасьютикал Компани Лимитед |
Способ получения препарата с покрытием
|
|
TWI367759B
(en)
*
|
2003-02-20 |
2012-07-11 |
Santarus Inc |
A novel formulation, omeprazole antacid complex-immediate release, for rapid and sustained suppression of gastric acid
|
|
RU2375048C2
(ru)
*
|
2003-07-17 |
2009-12-10 |
Д-Р Редди'С Лабораторис Инк. |
Фармацевтическая композиция с набухающим покрытием
|
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US20070292498A1
(en)
*
|
2003-11-05 |
2007-12-20 |
Warren Hall |
Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
|
|
CN1311824C
(zh)
*
|
2004-04-21 |
2007-04-25 |
常州市第四制药厂有限公司 |
奥美拉唑肠溶微粒制剂及制备方法
|
|
US8815916B2
(en)
*
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
|
ATE425791T1
(de)
*
|
2005-07-29 |
2009-04-15 |
Rottapharm Spa |
Kombination aus itriglumid und ppi zur behandlung von gastrointestinalen- und assozierten krankheiten
|
|
US20100297226A1
(en)
*
|
2006-06-01 |
2010-11-25 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
|
KR101436516B1
(ko)
*
|
2007-07-23 |
2014-09-02 |
주식회사태평양제약 |
코팅된 펠렛을 함유하는 현탁정 및 이의 제조방법
|
|
KR101104349B1
(ko)
*
|
2007-09-28 |
2012-01-16 |
주식회사 씨티씨바이오 |
에소메프라졸 함유 약학 조성물
|
|
UA99758C2
(ru)
*
|
2008-03-28 |
2012-09-25 |
Феррер Интернасиональ С.А. |
Капсула для профилактики сердечно-сосудистых заболеваний
|
|
MX2011001341A
(es)
|
2008-08-19 |
2011-03-29 |
Xenoport Inc |
Prodrogas de metil hidrogeno fumarato, sus composiciones farmaceuticas, y metodos de uso.
|
|
US9597292B2
(en)
|
2012-08-22 |
2017-03-21 |
Xenoport, Inc. |
Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
|
|
EP2887934A1
(en)
|
2012-08-22 |
2015-07-01 |
XenoPort, Inc. |
Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
|
|
CN102961356A
(zh)
*
|
2012-12-11 |
2013-03-13 |
山西云鹏制药有限公司 |
一种含奥美拉唑的蓝色肠溶片剂的制备方法
|
|
US10179118B2
(en)
|
2013-03-24 |
2019-01-15 |
Arbor Pharmaceuticals, Llc |
Pharmaceutical compositions of dimethyl fumarate
|
|
JP2016534133A
(ja)
|
2013-09-06 |
2016-11-04 |
ゼノポート，インコーポレイティド |
（ｎ，ｎ−ジエチルカルバモイル）メチル メチル（２ｅ）ブト−２−エン−１，４−ジオエートの結晶形態、その合成方法及び使用
|
|
US20150079180A1
(en)
*
|
2013-09-18 |
2015-03-19 |
Xenoport, Inc. |
Nanoparticle compositions of dimethyl fumarate
|
|
US9999672B2
(en)
|
2014-03-24 |
2018-06-19 |
Xenoport, Inc. |
Pharmaceutical compositions of fumaric acid esters
|
|
US20170042806A1
(en)
|
2015-04-29 |
2017-02-16 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
|
JPWO2021153525A1
(enExample)
|
2020-01-27 |
2021-08-05 |
|
|
|
KR102432084B1
(ko)
|
2021-11-16 |
2022-08-12 |
알리코제약(주) |
S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제
|
|
JP2025532389A
(ja)
|
2022-10-04 |
2025-09-29 |
ザビリュク，アルセニー |
大動脈弁の石灰化の抑制
|